chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt. was here along with his younger brother and sister. the vaccines were drawn up and labeled according to each child. the situation was very chaotic before and during vaccine administration. writer accidently grabbed the wrong vaccines although they were separated accordingly. supervisor was notified and mom was very understanding. provider did talk with mom and writer was apologetic. mom was still willing to proceed with the vaccinations of the other children as well as come bac k to have pt. vaccinated with intended vaccines.
he was in bed with fever; This is a spontaneous report from a contactable consumer or other non hcp from. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, patient experienced he was in bed with fever. The outcome of the event was unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Patient c/o dizziness.  Given Juice and crackers, .  Patient reports having a small meal for breakfast.  Patient stable and released from the vaccination site.
1st dose. - Moderna - rash around injection occurred 1 week later and progressed down injection side of upper arm including hard lump at injection. Area felt hot.  Entire arm ached.
Initial report received on 17 October 2007, and follow-up information was received on 23 October 2007, and 24 October 2007 from a physician.  A female patient (demographics not provided), who had no previous history of migraines, no concurrent illnesses, no pre-existing medical history, or use of other medications, had received a second intramuscular dose of IMOVAX (lot number A0208-2) in the deltoid muscle on 27 September 2007.  The patient had received the first dose of IMOVAX on 20 September 2007.  The indication for IMOVAX was preparation for the patient to be a donor for Rabies Immune Globulin.  Twenty-four hours post-vaccination of the second dose of IMOVAX on 27 September 2007, the patient developed migraine type headaches.  She was treated with over the counter analgesics and was to follow-up with her own health care provider.  On 23 October 2007 and on 24 October 2007 additional information was received from the physician stating the patient had been diagnosed with Epstein-Barr and the headaches were considered to be secondary to the Epstein-Barr diagnosis.  The patient recovered from the headaches on 23 October 2007 (approximately 25 days after onset).  Additional information has been requested.  The reporter for this case is the same as for case 2007-03512.  28 January 2008:  A corrective version was created with the same latest received date as the last version (17 October 2007) for the sole purpose of adding the term "cluster" to the narrative as per internal guidelines.  This case is part of a cluster of two cases that came from the same reporter, case 2007-03512 involves a patient who received IMOVAX, lot number A0208-2, and developed migraine type headaches.  No other relevant medically significant information was added to the case.
Neck on left side down to shoulder feels tight.; Neck on left side down to shoulder is painful; Headache; tired; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), MUSCLE TIGHTNESS (Neck on left side down to shoulder feels tight.), NECK PAIN (Neck on left side down to shoulder is painful), HEADACHE (Headache) and FATIGUE (tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm sore). On 11-Feb-2021, the patient experienced HEADACHE (Headache) and FATIGUE (tired). On 12-Feb-2021, the patient experienced MUSCLE TIGHTNESS (Neck on left side down to shoulder feels tight.) and NECK PAIN (Neck on left side down to shoulder is painful). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm sore), HEADACHE (Headache) and FATIGUE (tired) had resolved and MUSCLE TIGHTNESS (Neck on left side down to shoulder feels tight.) and NECK PAIN (Neck on left side down to shoulder is painful) had not resolved.            No Concomitant Medications were  provided by Reporter.   This case was linked to MOD-2021-021570 (Patient Link).
Modern a Covid-19 Vaccine ERA Hearing loss and high pitched Tinnitus in right ear
Patient admitted to hospital on 11/20/21 with positive for COVID s/p 2 doses of Moderna on 1/29/21 & 2/26/21
Flu; Initial information was received on 08-Oct-2021 regarding an unsolicited valid serious case received from social media from consumer/non-health care professional via regulatory authority (under reference number - US-SA-SAC20211012000839).  This case involves adult patient of unknown age and gender patient who experienced flu (influenza), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.; Sender's Comments: This case involves adult patient of unknown age and gender patient who experienced flu (influenza), after vaccination with INFLUENZA VACCINE. The time to onset is compatible with the role of the vaccine. However, patient's medical condition at time of vaccination, Lab data and other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the individual vaccines cannot be assessed.
I already had a mouth sore about a week before the vaccine. The very next day that I received the vaccine started getting worse. The very day I did not notice anything but then 24-48 hours after the vaccine it started being pretty bad and it got a point where it got so bad  the whole left side of my face swollen up, my tonsils, my neck, down the throat, only on the left side of my face.  At one point it was hard to swallow (NY Eve), it was hard to swallow and breathe. I had just started taking the medication my DDS prescribed and it was not really helping yet. On New Years day when I woke up a little better.  It took about 4-5 days for the swelling to go down. After 2 doses of the medication prescribed the pain was much more bearable and the swelling started going down. On 01/02/2021 my dentist cauterized some of the sores in my mouth,
Child loss the use of her muscles, blood pressure unstable, could not control eye movement or control body temp. My child could not breathe on her own (on ventilator for 3 weeks), could not talk or walk - diagnosed w/ Guillain-Barre Syndrome. Treatment - plasma exchange, intense physical therapy. 9/3/09 Hospital records received DOS 5/5/09 to 5/6/09. Assessment: S/P respiratory arrest, Pica R/O accidental poisoning, ataxia, pneumonia, sinusitis, mastoiditis, bilateral otitis media, asthma. Patient admitted with 4 day history of ear infection and sinusitis. Presented less active with head directed to the right and downwards, torticollis. Walk unsteady, wide-based gait. The child 'not acting herself'. Cough, nasal congestion. Typmanic membranes red with effusion. Throat congestion. Deep tendon reflexes not elicited. Respirory arrest. Pupils sluggish but reactive to light. Rhonchi. Patient transferred. 11/16/09 ICD9 codes: 719.7, 728.87, 383.0, 461.9, 493.90, 781.3, 382.9, 486, 799.1.
Red rash that is itchy, feels like knots - dose was given subcut instead of IM on Mon 10/7. Rash developed 10/9
Felt nauseous, while fast-walking to the bathroom, I fainted in the hallway and was unconscious for about 30 seconds. woke up with extreme perspiration, inability to move, nausea which lasted about 10 minutes. Headache, fatigue, and light-headedness lasted until about 1pm
Hives on Chest, between shoulder and neck area, upper back / Hives on stomach and lower back; Redness; Itching; A spontaneous report was received from a Consumer concerning a 50-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events hives on chest, between shoulder and neck area, upper back / urticaria, redness / erythema, itching / pruritus, hives on stomach and lower back / urticaria.  The patient's medical history was not provided. Concomitant medications reported were Warfarin: 9 mg Once day for drug use for unknown indication.  On 25 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Jan 2021, upon 40 minutes after vaccination, the patient broke out in hives that some on the chest, between shoulder and neck area, upper back, redness and itchiness. The patient took Diphenhydramine liquid about 20mg (7.5ml) at 2pm. When the medicine started to wear off, the patient had hives on stomach, lower back, redness and itchiness. So again took Diphenhydramine (7.5ml) at 11pm. Then the small hives started to subside and the larger ones subsided one day after.  Treatment details included Diphenhydramine 20 mg: 7.5 mL at 2 pm. 7.5 mL again at 11 pm on 25Jan2021.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events hives on chest, between shoulder and neck area, upper back, redness, itching and hives on stomach and lower back was resolved on 27 Jan 2021.
Information has been received from a physician concerning a 66 years old male, with no illness at time of vaccination, with gout, hypertension and hypercholesterolaemia and a history of chickenpox who on 22-FEB 2008, was vaccinated with a first dose of 0.65 ml of ZOSTAVAX (Merck) (lot no 659267/1836U) IM, into the left arm.  Concomitant therapy included LIPITOR, allopurinol, DYAZIDE (also reported as MAXZIDE), aspirin and sotolol.  On 29-AUG-2008, the patient developed shingles on left mid thorax.  The number of lesions was unknown.  There was no rash at the site of elsewhere within 42 days of the vaccination.  The patient had no recent exposure to chickenpox or herpes zoster.  Two weeks after the onset date of the event adverse, on approximately, 12-SEP-2008, the patient recovered from shingles.  The patient was seen by physician and sought unspecified medical attention.  A specimen was not collected for PCR.  No further information is available.
Dizziness, nausea, room spinning 1 to 5 mins after shot. Pt was monitored, rest, seated with feet elevated, ice compress behind head/neck as needed, water. Monitored 90 mins. Driven home. Follow-up call, pt felt fine.
Patient got the vaccination, stood up and fainted, hitting his head. Mother of the patient said she is a nurse practitioner and stated that she did not want any additional follow-up and took the child home.
On day 7 I noticed what looked like a mosquito bite on upper left arm and same on right arm.  By the next day, there were numerous marks on my left arm including my hand.  The marks were very itchy. It resembled chicken pox or poison ivy.  The marks continued up the left of my face and and into my hair line and up my ear. I was also feeling an itchy painful burning in my private area.  It was very painful  to pass urine or have a bowel movement.  The rash continued to break out all over my body for 5 or 6 days.  I was put on Prednisone for 17 days.  I did not feel the prednisone helped.  At 2 1/2 weeks I still have the rash although it is fading.
acute stroke secondary to intraventricular bleed in left hypothalamus and intraventricular blood; acute stroke secondary to intraventricular bleed in left hypothalamus and intraventricular blood; This spontaneous report as received from a lawyer refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant medications were not reported.  On 01-DEC-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot number and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).         On an unknown date, the patient experienced slurring speech, development of facial droop and loss of consciousness and was later diagnosed with an acute stroke secondary to intraventricular bleed in left hypothalamus and intraventricular blood with no mass effect. The patient sustained severe and permanent personal injuries.  The outcome of haemorrhagic stroke and intraventricular haemorrhage was unknown.     The reporter considered haemorrhagic stroke and intraventricular haemorrhage to be related to Zoster Vaccine Live(ZOSTAVAX).     Upon internal review, the events of haemorrhagic stroke and intraventricular haemorrhage were considered medically significant and disabling events as its were permanent injuries.
Very itchy, hot , very red area on arm about two inches below injection site down to elbow crease (about 3 to4 by 6 to 7 inches) beginning day after injection. Applied OTC 1% cortisone cream 4 times daily. On Feb 22 seems to be slightly better at least less itchy.
Initial report received from a Healthcare professional on 26 April 2012. MIS/VIS number: 12-0248. This case is linked with AER n# 2012-04562 case received under same MIS/VIS number by same reporter and similar adverse events occurred after administration of PENTACEL lot number C4163AA. A 15-months-old patient, whose medical history and concomitant therapy were not reported, had received a dose of PENTACEL (lot number C4163AA, route and anatomical site of administration was not reported) around a month ago on unspecified date. On an unspecified date the patient was developed leg swelling and redness. The lab details and corrective treatment details were not provided. The outcome of event was not reported. List of document held by sender: none.
feel terrible today; This spontaneous case was reported by a pharmacist and describes the occurrence of MALAISE (feel terrible today) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Dec-2021, the patient experienced MALAISE (feel terrible today). At the time of the report, MALAISE (feel terrible today) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported   Reporter did not allow further contact
Sob, low grade fever, bodyaches initially. Then persistent low grade fever, elevated liver GGT,  ALT, AST, CRP nonhs, mild changes wbc diff, mild hepto and splenomegaly,
It started as fatigue when I got home. I woke up and felt my jaw dropping and I thought it was because I had slept on the wrong side. I went back to sleep. I woke up a little later on and I noticed that my eye was not open up properly. I went back to sleep. I woke up again and I noticed I wanted to say something to my husband and I had slurred speech. I thought I was having a stroke. I went to the ER. The nurse examined me and asked me to lift my eyebrows and do other maneuvers. She said I had Bell?s palsy. When I saw the doctor he said there was a small group that did have an adverse side effect after getting the Moderna vaccine and unfortunately I was one of them. They did a CT scan and blood work. They prescribed me some medications. They put me on Steroids and antiviral. Then, a week later I had an appointment at the neuro-ophthalmologist, I kept having severe headaches and ear pain. When I went in to get my eyes checked they noticed my eye pressure was severely high. They sent me to the ER to get admitted to the hospital. I ended up having another CT scan and MRI. On 03/23/2021 I was at the hospital for 3 days because they could not get the pressure down It should have been a 20 and mine was at 83. They were concerned. They talked about doing a possible biopsy of the nerve. But the MRI ruled that out, so they did not have to do it. I can hardly speak, see, and eat. I still have slurred speech. My right eye still does not close fully. I have to use sunglasses at all times. I can only drink out of a straw. My face is still paralyzed from the right. I am currently being seen by a Neuro-ophthalmologist, PCP, Rheumatologist, Neurologist, ENT.
Pt was administered Anthrax vaccine 0.5ml to right arm at 3:14pm. Shortly after, pt began coughing while in waiting room. Pt then stated at this time that she coughed last time she received both the Typhoid and Anthrax vaccine on 6/6/18 but that it lasted for about five minutes. We continued to monitor pt and noted that cough was becoming worse with time. At 3:30pm pt was brought back to treatment room and vital signs were taken as: BP 130/90 HR 87 while sitting radial pulse noted to be weak and thready, RR was difficult to assess due to frequent coughing. No local reaction noted to injection site. After a few minutes, pt then informed she was feeling "mouth watery" "difficulty to swallow" and "hot and cold." Pt was placed on 100% NRB 15L with no improvement. 911 was called by another service member. EPIPEN 0.3mg was given IM to left thigh at 3:36pm. Pt noted to cough slightly less and informed that swallowing felt better. VS taken at 1541 as: BP 120/82 HR 114 Spo2 99% on 4L NC, RR continued to be difficult to assess due to frequent coughing. Coughing then produced to get worse. Second dose EPIPEN given IM to right thigh at 1542. Ambulance team arrived at this time. Report was given and pt transferred to local  hospital.
Patient contracted COVID-19 after receiving two COVID-19 vaccine doses (Pfizer series completed on 4/30/21). Patient presented to ED on 7/25  c/o rash on his back, feeling generalized fatigue and weakness for last few days and had tested positive for SARS-CoV-2. Patient remained stable and was discharged from ED on same day. On 7/29 patient returned c/o headache and SOB, he was placed on 3.5L NC and given albuterol neb, acetaminophen and prednisone.
Tenderness at injection site  Light throbbing headache Strong throbbing headache Fatigue
Pt vaccinated with FLUOGEN apparent cardiac arrest - no breath/pulse 8PM - CPR initiated - transported to hosp where he expired.
Myalgia and right arm pain, followed by right arm swelling, then right ankle swelling, then left ankle swelling, then nerve pain that goes down patient's left arm into his fingers. Gabapentin 100 mg tid.
(L) arm cellulitis/swelling, syncope, muscle weakness (generalized) unable to ambulate & complete ADLs, severe back pain, concussion from syncopal episode Patient has gained mobility back and able to complete ADLs. Patient was unable to complete these for 2 wks after the vaccine was given. She continues to have minimal muscle weakness & continue to have severe back pain and moderate (L) arm pain & swelling. Patient declined a work up in the Emergency dept and/or our office for the reaction to the vaccine. Patient verbalized all symptoms including concussion from syncopal episode that occurred that night - 12/13/19.
Presented with diarrhea and generalized weakness. Tested positive for COVID-19. tx w/abx & steroids; did not require O2; DC to SNF
I have never had headaches until after I had the 1st vaccine. Even after my 2nd Pfizer vaccine on 8/15, I continue to get a headache daily.  They come and go throughout the day.   2nd vaccine lot was FD8448.
Pt received Dose 1 of COVID vaccine. Nurse checked on patient five minutes post injection and patient reported that she was having some itching at the site. Patient advised would continue to monitor. Slight reddness no raised rash. Checked on patient at 1100, patient asked about soreness of her throat. Patient states that it had just started approx five minutes prior. Patient reports lump sensation in her throat "like something in throat when have cold." PA-C and RN came in for observation and eval. Decided patient to come to urgent care for futher medical eval and observations. Vitals monitored before leaving and WNL (see chart). Patient ambulated per self to urgent care with provider and nurse.  At convenient care, pt reports scratchy throat and feels like "something" is in her throat. Denies SOB or cough. Uvula appears slightly swollen, but no previous exams for comparison. Pt given diphenhyramine 25 mg IM x 1 and 15 minutes later she reported mild improvement in swelling, but no change on exam. 45 min after Benadryl she reported feeling tired but improvement in symptoms. Uvula appeared to be smaller on re-examination. Instructed to take 50 mg Benadryl Q 6 hours for the next day. Discharged to home with perscription for albuterol 90 mcg/inh 2 puffs Q6hrs PRN
Pt was seen Saturday 4/26 and given the shot by a volunteer school nurse. Mother became aware of the child having a swollen red arm to the elbow on the 27th. On the 28th child's arm was swollen to about 1" above wrist. looked like Popeyes arm per Mother. Taken to seeDr.  . To give Benadyl as needed. On the 29th redness diminished but arm remains swollen
This is a spontaneous report from a contactable consumer. A 44-year-old (non-pregnant) female patient received the 1st dose, BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FA7485), at the age of 44, via an unspecified route of administration, left arm, on Aug 10, 2021, 12:30, single dose, for COVID-19 immunisation. The patient's medical history included asthma, from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took sulfa (sulfa/penicillin) and experienced known allergies. Patient did not receive other vaccine in four weeks and other medications in two weeks. On Aug 10, 2021, at 16:00, patient experienced muscle cramps, fatigue, shortness of breath, wheezing, headache, fever and chills. The patient received rescue inhaler as treatment for the events. The outcome of the events: not recovered. The patient did not have COVID-19 prior to vaccination. Patient has not tested for COVID-19 post vaccination. No follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information expected.
Information has been received from a physician concerning a female who in approximately 2007 was vaccinated IM with the first dose of GARDASIL (lot# not provided). The patient completed series of 3 doses of GARDASIL was experiencing discomfort on both arms. The patient had started GARDASIL vaccination one year ago. The patient's both arms are achy when she either lays or leans on them. She has had pain since the completion of the series. Unknown medical attention was sought by calling the physician's office. At the time of reporting the patient had not recovered. Additional information has been requested.
An 8-year-old patient incorrectly scheduled on our "12+" COVID-19 vaccine clinic, was administered the 12+ dose. Additionally, patient only had 15 days from dose 1 in series (versus minimum spacing of 17 days to be considered valid).